Keyphrases
Multiple Sclerosis
100%
Biological Efficiency
100%
Glatiramer Acetate
100%
Ordered Architectures
100%
Treatment Conditions
28%
Performance Improvement
14%
Size-and-shape
14%
Polymeric Drugs
14%
C57BL
14%
Mouse Model
14%
Spherical Shape
14%
Star-shaped
14%
Adverse Effects
14%
Molecular Size
14%
Molecular Shape
14%
Bone Marrow-derived Dendritic Cells
14%
Intraperitoneal Injection
14%
Treatment Options
14%
RAW264.7 Macrophages
14%
Multiple Sclerosis Treatment
14%
Leukocyte Infiltration
14%
Spinal Cord Pathology
14%
Demyelination
14%
Experimental Autoimmune Encephalomyelitis
14%
Patient Adherence
14%
Copolypeptide
14%
Biochemistry, Genetics and Molecular Biology
Animal Model
100%
Low Drug Dose
100%
Molecular Weight
50%
Macrophage
50%
Leukocyte
50%
Dendritic Cell
50%
Polymerization
50%
Mouse Model
50%
C57BL 6 Mouse
50%
Patient Compliance
50%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
Glatiramer
100%
Disease
14%
C57BL 6 Mouse
14%
Mouse Model
14%
Intraperitoneal Injection
14%
Adverse Event
14%
Demyelination
14%
Experimental Allergic Encephalitis
14%
Immunology and Microbiology
Multiple Sclerosis
100%
Low Drug Dose
28%
Macrophage
14%
Mouse Model
14%
Molecular Weight
14%
Leukocyte
14%
Polymerization
14%
Bone Marrow Derived Dendritic Cell
14%
Spinal Cord
14%
C57BL 6 Mouse
14%
Experimental Allergic Encephalitis
14%